The FAA has proposed replacing prescriptive onboard emergency medical-kit rules for U.S. Part 121 airlines with performance-based standards that would let carriers determine the exact contents of their kits. The move would require medical supplies capable of addressing nine serious in-flight emergencies, while stopping short of mandating epinephrine auto-injectors for allergic reactions.
The proposal would remove the existing item-by-item checklists for first-aid kits and emergency medical kits and shift responsibility to airlines and their medical advisers to select appropriate equipment. The covered conditions include cardiac emergencies, breathing problems, gastrointestinal emergencies, opioid overdose, childbirth, seizures, severe allergic reactions, major bleeding and hypoglycemia.
Reuters reported that aircraft would still need to carry an external defibrillator under the revised framework. The proposal also appears to align with Congress’s direction in the FAA Reauthorization Act of 2024, including requirements linked to opioid-reversal medication and supplies for unexpected childbirth. If adopted, the rule would affect all U.S. commercial airlines operating under Part 121 and could change the industry’s long-standing approach to standardising onboard medical equipment.